Hosted on MSN1mon
Investigation raises new concerns over landmark trial for top selling anti-platelet drug
that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the US and Brilique in Europe), manufactured by AstraZeneca. Peter Doshi, senior editor at The BMJ ...
Healio7y
Treatment - STEMI Medical Therapy
P2Y12 receptor antagonists (clopidogrel, prasugrel, ticagrelor (Brilinta, AstraZeneca) and ticlopidine) are indicated in all STEMI cases unless urgent surgery is required. Clopidogrel can also be ...